Temporal profiling of the functional phosphoproteome in M. tuberculosis infected
Temporal profiling of the functional phosphoproteome in M. tuberculosis infected
批准号:
8791881
负责人:
Sarah A Stanley
金额:
$19.6万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-02-01 至 2017-01-31
关键词:
AKT inhibitionAntibioticsApoptosisArchitectureAttenuatedCell physiologyCessation of lifeComplementComplexData SetDevelopmentDiseaseDrug resistanceEnvironmentEpidermal Growth Factor ReceptorEventFutureGene ExpressionGoalsGrowthHealthHumanImmuneImmune responseInfectionKnowledgeLeadMammalian CellMass Spectrum AnalysisMediator of activation proteinMolecularMonitorMorbidity - disease rateMycobacterium tuberculosisNutrientOutcomePathogenesisPathway interactionsPhagosomesPharmaceutical PreparationsPhosphorylationPhosphorylation SitePhosphotransferasesProteinsProteomeProteomicsProto-Oncogene Proteins c-aktPublic HealthPublishingRNA InterferenceRegulationRegulatory PathwayResearchResourcesRoleSignal PathwaySignal TransductionTechnologyTimeTuberculosisTwo-Dimensional Gel ElectrophoresisVaccine AdjuvantVaccinesVirulenceWorkantimicrobialbasecombatdesigninhibitor/antagonistinterestkinase inhibitormacrophagemonocytemortalitynext generationnovel strategiesnovel therapeuticspathogenpreventprogramsresearch studyresponsescreeningsmall moleculestemtargeted treatmenttemporal measurementtherapeutic developmenttherapeutic targettherapeutic vaccinetranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): It is estimated that 2 billion people are infected with M. tuberculosis, an important human pathogen that causes significant morbidity and mortality worldwide. A better understanding of the molecular mechanisms of M. tuberculosis pathogenesis is necessary for the rational design of the next generation of drugs and vaccines. Our goal is to elucidate host signaling mechanisms exploited by M. tuberculosis for growth and persistence in macrophages. Our central hypothesis is that kinase signaling leads to a gene expression program in infected macrophages that promotes an insufficient response to infection thereby facilitating Mtb growth and survival. We have identified several kinases in macrophages that function to support M. tuberculosis replication during infection, indicating either that they re activated by M. tuberculosis as part of a virulence strategy or that they are negative regulators of innate anti-microbial pathways. Of specific relevance to this proposal are inhibitors of the mammalian kinases AKT and EGFR that disrupt the ability of M. tuberculosis to replicate in human primary macrophages. Our approach is to utilize recent advances in global proteomic and phosphoproteomic technologies to characterize macrophage-signaling pathways that are activated by infection with M. tuberculosis. In addition, we will use these technologies to elucidate the functional phosphoproteome by identifying of downstream targets of AKT and EGFR in M. tuberculosis infected macrophages. In aim 1, we describe the use of proteomics and phosphoproteomics to characterize signaling events resulting from M. tuberculosis infection of human primary monocyte-derived macrophages with high temporal resolution using 2D gel electrophoresis and mass-spectrometry based proteomics and phosphoproteomics to monitor phosphorylation sites on a global scale. In aim 2 we utilize the same strategy to identify differences in the proteome and phosphoproteome in the context of inhibition of AKT and, independently, EGFR. Results from the proteomic profiling will be integrated with existing transcriptomic and screening datasets to further refine the architecture of the signaling network activated by M. tuberculosis infection. In addition, the results will be used to motivate future hypothesis driven experiments seeking to describe the molecular mechanisms by which key kinase regulators support M. tuberculosis virulence in macrophages.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of nanocompartments in M. tuberculosis pathogenesis
-
批准号:10020315
-
项目类别:
-
资助金额:$38.11万
-
财政年份:2019
-
负责人:Sarah A Stanley
-
依托单位:
The role of nanocompartments in M. tuberculosis pathogenesis
-
批准号:10247654
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2019
-
负责人:Sarah A Stanley
-
依托单位:
Modeling tuberculosis infection in a new collection of genetically diverse mice
-
批准号:9808825
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2019
-
负责人:Sarah A Stanley
-
依托单位:
The role of nanocompartments in M. tuberculosis pathogenesis
-
批准号:10689049
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2019
-
负责人:Sarah A Stanley
-
依托单位:
The role of nanocompartments in M. tuberculosis pathogenesis
-
批准号:10462785
-
项目类别:
-
资助金额:$37.99万
-
财政年份:2019
-
负责人:Sarah A Stanley
-
依托单位:
The role of lipid droplets in immunity to M. tuberculosis infection
-
批准号:9278110
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2016
-
负责人:Sarah A Stanley
-
依托单位:
The role of lipid droplets in immunity to M. tuberculosis infection
-
批准号:9168274
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2016
-
负责人:Sarah A Stanley
-
依托单位:
Metabolic regulation of macrophage function during M. tuberculosis infection
-
批准号:10626926
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2015
-
负责人:Sarah A Stanley
-
依托单位:
Metabolic regulation of macrophage function during M. tuberculosis infection
-
批准号:9049446
-
项目类别:
-
资助金额:$38.26万
-
财政年份:2015
-
负责人:Sarah A Stanley
-
依托单位:
Metabolic regulation of macrophage function during M. tuberculosis infection
-
批准号:10410449
-
项目类别:
-
资助金额:$38.81万
-
财政年份:2015
-
负责人:Sarah A Stanley
-
依托单位:
Project 4: The intersection of innate and adaptive immunity to M. tuberculosis
-
批准号:10190581
-
项目类别:
-
资助金额:$43.65万
-
财政年份:2004
-
负责人:Sarah A Stanley
-
依托单位:
Project 4: The intersection of innate and adaptive immunity to M. tuberculosis
-
批准号:10400185
-
项目类别:
-
资助金额:$41.41万
-
财政年份:2004
-
负责人:Sarah A Stanley
-
依托单位:
Project 4: The intersection of innate and adaptive immunity to M. tuberculosis
-
批准号:10655298
-
项目类别:
-
资助金额:$43.57万
-
财政年份:2004
-
负责人:Sarah A Stanley
-
依托单位:
Core B: BSL3 Advanced Technologies and Animal Infection Core
-
批准号:10190577
-
项目类别:
-
资助金额:$26.33万
-
财政年份:2004
-
负责人:Sarah A Stanley
-
依托单位:
Core B: BSL3 Advanced Technologies and Animal Infection Core
-
批准号:10400181
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2004
-
负责人:Sarah A Stanley
-
依托单位:
Core B: BSL3 Advanced Technologies and Animal Infection Core
-
批准号:10655291
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2004
-
负责人:Sarah A Stanley
-
依托单位:
海外基金